Gene analysis (phosphatase and tensin homolog), full sequence analysis
Medicare pricing data for 62 providers across 5 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (phosphatase and tensin homolog), full sequence analysis (HCPCS code 81321) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $582.79, but hospitals typically charge $693.11 — a 1.2x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $582.79, your out-of-pocket cost would be approximately $116.56. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $582.79 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Pennsylvania | $588 | $603 | 2 | 94 | +0.9% |
| Texas | $588 | $759 | 12 | 78 | +0.9% |
| California | $588 | $601 | 1 | 4,580 | +0.9% |
| New Jersey | $588 | $722 | 10 | 448 | +0.9% |
| Florida | $581 | $713 | 28 | 20,117 | -0.2% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber